Victor Vaughn is VP at SUPERNUS PHARMACEUTICALS INC (SUPN). They have made 6 open-market trades across 1 company since 2018, most recently 2018-04-19.
CIK 0001567077
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 9,344 | $354K |
Shares reported on the most recent Form 4, priced at the 2018-04-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL | 2018-04-18 | 2018-04-20 | $48.26 | $1.2M | -3.9% | +12.8% | +11.3% |
| SUPN | SELL | 2018-04-05 | 2018-04-09 | $45.33 | $4.8M | +7.0% | +5.0% | +14.1% |
| SUPN | SELL | 2018-01-17 | 2018-01-17 | $46.26 | $1.1M | -10.9% | -16.7% | +0.7% |
| SUPN | SELL | 2018-01-12 | 2018-01-16 | $45.03 | $518K | -3.3% | -8.6% | +5.7% |
| SUPN | SELL | 2018-01-09 | 2018-01-09 | $42.04 | $631K | +4.5% | -12.3% | +7.1% |
| SUPN | SELL | 2018-01-02 | 2018-01-04 | $40.11 | $2.2M | +15.7% | -4.5% | +13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.